Surgical Treatment of Hypertensive Cerebral Hemorrhage

Abstract

Intracerbral hemorrhage (ICH) refers to primary non-traumatic hemorrhage in the parenchyma, also known as spontaneous cerebral hemorrhage, accounting for 20%-30% of acute cerebrovascular diseases. Every year 2 million to 3 million people in the world suffer from intracerebral hemorrhage, accounting for 10%-15% of all new strokes, and the total incidence of intracerebral hemorrhage in the world is 24.6/ (100,000 · year). In China, the incidence of cerebral hemorrhage is 60-80/ (100,000 · year), which is much higher than that of other Asian countries. Primary intracerebral hemorrhage accounts for 80%-85%, and primary hypertensive intracerebral hemorrhage combined with hypertension accounts for 50%-70% ^[1]. Hypertensive intracerebral hemorrhage accounts for about 50% of the causes of non-traumatic intracerebral hemorrhage, and its mortality rate takes the first place in non-traumatic intracerebral hemorrhage ^[2]. Hypertensive intracerebral hemorrhage has rapid onset, high mortality rate and slow recovery, and often leaves various degrees of neurological dysfunction. This paper analyzes the pathological features of hypertensive intracerebral hemorrhage, the clinical features of the bleeding site, the indications, timing, surgical methods and the advantages and disadvantages of surgical treatment, hoping to provide reference for the selection of surgery for clinicians.